Leucovorin calcium - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for leucovorin calcium and what is the scope of freedom to operate?

Leucovorin calcium is the generic ingredient in three branded drugs marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Hainan Poly, Hikma, Meitheal, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, Am Regent, Fresenius Kabi Usa, Mylan Labs Ltd, Sagent Pharms, Sagent Pharms Inc, Glaxosmithkline, Novast Labs, Ani Pharms, Barr, Epic Pharma Llc, Leading, Par Pharm, and Xanodyne Pharm, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for leucovorin calcium. Fourteen suppliers are listed for this compound.

Summary for leucovorin calcium

US Patents:	0
Tradenames:	3
Applicants:	24
NDAs:	53
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	63
Clinical Trials:	477
Patent Applications:	7,027
Drug Prices:	Drug price trends for leucovorin calcium
What excipients (inactive ingredients) are in leucovorin calcium?	leucovorin calcium excipients list
DailyMed Link:	leucovorin calcium at DailyMed

See drug prices for leucovorin calcium

Recent Clinical Trials for leucovorin calcium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fudan University	Phase 3
Jonsson Comprehensive Cancer Center	Phase 1/Phase 2
Arcus Biosciences, Inc.	Phase 1/Phase 2

See all leucovorin calcium clinical trials

Pharmacology for leucovorin calcium

Drug Class	Folate Analog

Medical Subject Heading (MeSH) Categories for leucovorin calcium

Antidotes
Vitamin B Complex

US Patents and Regulatory Information for leucovorin calcium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	LEUCOVORIN CALCIUM	leucovorin calcium	INJECTABLE;INJECTION	089384-001	Sep 14, 1987	AP	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmachemie	LEUCOVORIN CALCIUM	leucovorin calcium	TABLET;ORAL	073101-001	Mar 28, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	LEUCOVORIN CALCIUM	leucovorin calcium	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	207241-001	Mar 14, 2018		RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.